Restoration of impaired p38 activation by insulin in insulin resistant skeletal muscle cells treated with thiazolidinediones
We have previously reported that thiazolidinediones (TZDs) are able to restore the tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1, activation of phosphatidyl inositol 3-kinase and glucose uptake in insulin resistant skeletal muscle cells . In this study, we investigated the effects of insulin stimulation and TZDs on the role of mitogen-activated protein kinase (MAPK) in insulin resistant skeletal muscle cells. All the three MAPKs [extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 MAPK] were activated by insulin in the sensitive skeletal muscle cells. In contrast, activation of p38 MAPK was impaired in insulin resistant cells, where as ERK and JNK were activated by insulin. Treatment with TZDs resulted in the restoration of p38 MAPK activity in insulin resistant cells. The treatment of cells with p38 MAPK inhibitor, SB203580, blocked the insulin stimulated glucose uptake in sensitive as well as resistant cells and it also prevented the activation of p38 by insulin. These results suggest the potential involvement of p38 as well as the mechanistic role of TZDs in insulin resistance.
Unable to display preview. Download preview PDF.
- 2.Ludwig S, Hoffmeyer A, Goebeler M, Kilian K, Hafner H, Neufeld B, Han J, Rapp UR: The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem 273: 1917-1922, 1998CrossRefPubMedGoogle Scholar
- 3.Ishrath A, Kumar N, Dey CS: Differential activation of ERK and JNK by arsenite in mouse muscle cells. Comp Biochem Physiol 132C: 375-384, 2002Google Scholar
- 8.Farese RV: Insulin-sensitive phospholipid signaling systems and glucose transport. Update II. Exp Biol Med 226: 283-295, 2001Google Scholar
- 9.Cefalu WT: Insulin resistance: Cellular and clinical concepts. Exp Biol Med 226: 13-26, 2001Google Scholar
- 12.Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A: An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes. J Biol Chem 274: 10071-10078, 1999CrossRefPubMedGoogle Scholar
- 24.Chang PY, Le Marchand-Brustel Y, Cheatham LA, Moller DE: Insulin stimulation of mitogen-activated protein kinase, p90rsk, and p70 S6 kinase in skeletal muscle of normal and insulin-resistant mice. Implications for the regulation of glycogen synthase. J Biol Chem 270: 29928-29935, 1995CrossRefPubMedGoogle Scholar
- 30.Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M, Onishi Y, Ono H, Funaki M, Inukai K, Fukushima Y, Kikuchi M, Oka Y, Asano T: MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem 276: 19800-19806, 2001CrossRefPubMedGoogle Scholar
- 35.Pinset C, Gros F, Whalen R: Proliferation and differentiation of a myogenic line in synthetic media. CR Sean Acad Sci 295: 727-732, 1982Google Scholar
- 39.Nagase I, Yoshida S, Canas X, I Yukiko, Kimura K, Yoshida T, Saito M: Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes. FEBS Lett 461Google Scholar